Abstract:Chenglin Ye, 1, &ast Sizhe Zhu, 2, &ast Jingping Yuan, 1 Xiuxue Yuan 3 1 Department of Pathology, Renmin Hospital of Wuhan University, Wuhan, Hubei, People's Republic of China; 2 Department of Otolaryngology-Head and Neck Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Sciences and Technology, Wuhan, Hubei, People's Republic of China; 3 Medical College of Wuhan University of Science and Technology, Wuhan, Hubei, People's Republic of China &astThese authors contributed equally to this work Correspondence: Jingping Yuan; Xiuxue Yuan, Email ; Purpose: Crohn's disease (CD) represents a multifaceted inflammatory gastrointestinal condition, with a profound significance placed on unraveling its molecular pathways to enhance both diagnostic capabilities and therapeutic interventions. This study focused on identifying a robust macrophage-related signatures (MacroSig) for diagnosing CD, emphasizing the role of FPR1 in macrophage polarization and its implications in CD. Patients and Methods: Expression profiles from intestinal biopsies and macrophages of 1804 CD patients were retrieved from the Gene Expression Omnibus (GEO). Utilizing CIBERSORTx, differential expression analysis, and weighted correlation network analysis to to identify macrophage-related genes (MRGs). By unsupervised clustering, distinct clusters of CD were identified. Potential biomarkers were identified via using four machine learning algorithms, leading to the establishment of MacroSig which combines insights from 12 machine learning algorithms. Furthermore, the expression of FPR1 was verified in intestinal biopsies of CD patients and two murine experimental colitis models. Finally, we further explored the role of FPR1 in macrophage polarization through single-cell analysis as well as through the study of RAW264.7 cells and peritoneal macrophages. Results: Two distinct clusters with differential levels of macrophage infiltration and inflammation were identified. The MacroSig, which included FPR1 and LILRB2, exhibited high diagnostic accuracy and outperformed existing biomarkers and signatures. Clinical analysis demonstrated a strong correlation of FPR1 with disease activity, endoscopic inflammation status, and response to infliximab treatment. The expression levels of FPR1 were validated in our CD cohort by immunohistochemistry and confirmed in two colitis mouse models. Single-cell analysis indicated that FPR1 is predominantly expressed in macrophages and monocytes. In vitro studies demonstrated that FPR1 was upregulated in M1 macrophages, and its activation promoted M1 polarization. Conclusion: We developed a promising diagnostic signature for CD, and targeting FPR1 to modulate macrophage polarization may represent a novel therapeutic strategy. Keywords: Crohn's disease, macrophage, diagnostic signature, FPR1, machine learning Crohn's disease (CD) is a subtype of inflammatory bowel disease (IBD) that affects the gastrointestinal tract. 1 The disease is characterized by periods of remission and relapse, with symptoms ranging from abdominal pain and diarrhea to severe complications such as fistulas and intestinal obstruction. 2 Since the 20th century, the global incidence of CD has increased markedly, particularly in emerging industrialized nations within Asia, Africa, and South America. 3 This rise is attributed to changes in lifestyle, dietary habits, and increased exposure to environmental risk factors in these regions. 4 The pathogenesis of CD involves multiple factors, including genetic predisposition, environmental influences, and immune system dysregulation. 5 Dysfunction and hyperactivity in the immune response are key factors that contribute to uncontrolled inflammation, a defining feature of CD. 6 Consequently, addressing these factors is crucial in the treatment of CD. Macrophages play a pivotal role in maintaining intestinal immune homeostasis. 7,8 The transition of macrophages from protectors to aggressors, under the influence of environmental and genetic determinants, represents a crucial element of CD pathogenesis. 8 Macrophages present heterogeneity and are known for two main phenotypes: the pro-inflammatory M1 and the anti-inflammatory M2. M1 macrophages, stimulated by bacterial lipopolysaccharide (LPS), exacerbate inflammation through the production of cytokines like tumor necrosis factor alpha (TNF-α), interleukin (IL)-1β, IL-6, and IL-23. On the contrary, M2 macrophages, when activated by IL-4, boost tissue repair and resolution of inflammation by releasing anti-inflammatory cytokines like arginase 1 and IL-10. 9–12 In CD -Abstract Truncated-

Adropin regulates macrophage phenotype via PPARγ signalling: A preliminary study of adropin and Crohn's disease

Epigenetic Modulation In Periodontitis: Interaction Of Adiponectin And Jmjd3-Irf4 Axis In Macrophages

Adropin deficiency worsens TNBS-induced colitis

Low-dose adropin stimulates inflammasome activation of macrophage via mitochondrial ROS involved in colorectal cancer progression

Adiponectin and adiponectin receptor 1 overexpression enhance inflammatory bowel disease

Peucedanum Praeruptorum Dunn Polysaccharides Regulate Macrophage Inflammatory Response Through TLR2/TLR4-mediated MAPK and NF-κB Pathways.

Adropin Contributes to Anti-Atherosclerosis by Suppressing Monocyte-Endothelial Cell Adhesion and Smooth Muscle Cell Proliferation

FPR1, as a Potential Biomarker of Diagnosis and Infliximab Therapy Responses for Crohn's Disease, is Related to Disease Activity, Inflammation and Macrophage Polarization

CD1d1 Intrinsic Signaling in Macrophages Controls NLRP3 Inflammasome Expression During Inflammation.

Adropin Regulates Hepatic Glucose Production Via PP2A/AMPK Pathway in Insulin-Resistant Hepatocytes.

Adropin Slightly Modulates Lipolysis, Lipogenesis and Expression of Adipokines but Not Glucose Uptake in Rodent Adipocytes

Lower adropin expression is associated with oxidative stress and severity of nonalcoholic fatty liver disease.

Expression of peroxisome proliferator-activated receptor-gamma in macrophage suppresses experimentally induced colitis

The peptide hormone adropin regulates signal transduction pathways controlling hepatic glucose metabolism in a mouse model of diet-induced obesity

MCPIP1 restrains mucosal inflammation by orchestrating the intestinal monocyte to macrophage maturation via an ATF3-AP1S2 axis

Identification and characterization of a novel adiponectin receptor agonist adipo anti‐inflammation agonist and its anti‐inflammatory effects in vitro and in vivo

Stimulation of Adenosine A2a Receptor Regulates Peroxisome Proliferator Activated Receptors in Macrophages

Adiponectin promotes preadipocyte differentiation via the PPARγ pathway

Activation of Angiogenin Expression in Macrophages by Lipopolysaccharide Via the TLR4/NF-κB Pathway in Colitis.

Myeloid‐specific Dopamine D2 Receptor Signalling Controls Inflammation in Acute Pancreatitis Via Inhibiting M1 Macrophage

Adipokine Apelin Ameliorates Chronic Colitis in Il-10−/− Mice by Promoting Intestinal Lymphatic Functions